ACRV
Acrivon Therapeutics
$1.79
+$0.05 (+2.87%)Oct 28, 2026
Key metrics
The numbers that frame ACRV today
- Market cap
- $76.71M
- ROIC
- -103.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.27
- 52wk High
- $3.56
Growth
Revenue and earnings trend for ACRV
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ACRV
Is Acrivon Therapeutics a good buy?
Hold. Acrivon Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Acrivon Therapeutics is selling at a very high price.
What is the market capitalization of ACRV?
Acrivon Therapeutics's market capitalization is $76.71M.
What is the 52-week high for ACRV stock?
The 52-week high for Acrivon Therapeutics is $3.56. The current close of $1.79 is 49.7% below that high.
What is the 52-week low for ACRV stock?
The 52-week low for Acrivon Therapeutics is $1.27. The current close of $1.79 is 40.9% above that low.
Does ACRV stock pay dividends?
Acrivon Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACRV?
Acrivon Therapeutics's Debt / Equity ratio is 0.02.